DNA Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$14.00
68.27% Upside
Mean Price Target
$11.50
38.22% Upside
Lowest Price Target
$9.00
8.17% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
DNA Earnings Per Share (EPS) History
According to financial reports, DNA (NYSE: DNA) reported an actual EPS of $-1.45 for the quarter ending on Nov 06, 2025, compared to an estimated $-1.24, resulting in a 16.94% surprise. In the prior quarter (Aug 07, 2025), DNA recorded an actual EPS of $-1.1 with a -23.61% surprise. See DNA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
DNA has experienced notable EPS surprises, with the latest quarter ending Nov 06, 2025 showing a 16.94% beat. Previously, the quarter ending Aug 07, 2025 recorded a -23.61% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Nov 06, 2025 | -1.45 | -1.24 | +16.94% |
| Aug 07, 2025 | -1.1 | -1.44 | -23.61% |
| May 06, 2025 | -1.58 | -1.23 | +28.46% |
| Feb 25, 2025 | -1.82 | -1.45 | +25.52% |
| Nov 12, 2024 | -1.08 | -2.4 | -55.00% |
| Aug 08, 2024 | -0.10568 | -0.08 | +32.10% |

